A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients

Transfusion

Volumn 51, Issue 11, 2011, Pages 2480-2487

  Cesaro, Simone ^a,b,c,d,e   Zanazzo, Andrea Giulio ^a,b,c,d,e   Frenos, Stefano ^a,b,c,d,e   Luksch, Roberto ^a,b,c,d,e   Pegoraro, Anna ^a,b,c,d,e   Tridello, Gloria ^a,b,c,d,e   Dallorso, Sandro ^a,b,c,d,e  

^a UNIVERSITY OF PADOVA   (Italy)

^b Pediatric Hematology Oncology   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; TOPOTECAN; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CD34 SELECTION; CELL THERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EWING SARCOMA; FEMALE; GERM CELL TUMOR; GLIOBLASTOMA; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMOBILIZED CELL; LEUKAPHERESIS; MALE; MEDULLOBLASTOMA; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; NEUTROPENIA; NONHODGKIN LYMPHOMA; PEDIATRICS; PERIPHERAL BLOOD STEM CELL; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; RHABDOMYOSARCOMA; SCHOOL CHILD; SEPSIS; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INFANT; MALE; NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TRANSPLANTATION, AUTOLOGOUS;

EID: 80055014804     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03157.x     Document Type: Article

References (27)

1. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, Niederwieser D,. The EBMT activity survey 2008 impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174-91.
2. Gertz MA,. Current status of stem cell mobilization. Br J Haematol 2010; 150: 647-62.
3. Beyer J, Schwella N, Zingsen J, Strohscheer I, Schwaner I, Oettle H, Serke S, Huhn D, Stieger W,. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitors cells or bone marrow: a randomized comparison. J Clin Oncol 1995; 13: 1328-35.
4. Siena S, Piccart MJ, Holmes FA, Glaspy J, Hackett J, Renwick JJ,. A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily filgrastim in patients with stage II-IV breast cancer. Oncol Rep 2003; 10: 715-24.
5. Staber PB, Holub R, Linkesch W, Schmidt H, Neumeister P,. Fixed-dose single administration of pegfilgrastim versus daily filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2005; 35: 889-93. (Pubitemid 40667631)
6. Isidori A, Tani M, Bonifazi F, Zinzani P, Curti A, Motta MR, Rizzi S, Giudice V, Farese O, Rovito M, Alinari L, Conte R, Baccarani M, Lemoli RM,. Phase II study of a single pegfilgrastim injection as adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica 2005; 90: 225-31. (Pubitemid 40293285)
7. Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG,. Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study. Bone Marrow Transplant 2005; 35: 1165-9. (Pubitemid 40895172)
8. Martino M, Praticò G, Messina G, Irrera G, Massara E, Messina G, Console G, Iacopino P,. Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients. Eur J Haematol 2006; 77: 410-5. (Pubitemid 44483944)
9. Kroschinsky F, Holing K, Ehninger G,. The role of pegfilgrastim in mobilization of hematopoietic stem cells. Transfus Apher Sci 2008; 38: 237-44.
10. Putkonen M, Rauhala A, Pelliniemi TT, Remes K,. Single-dose of pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignacies. Ann Hematol 2009; 88: 673-80.
11. Hosing C, Qazilbash H, Kebriaei P, Giralt S, Davis MS, Popat U, Anderlini P, Shpall E, McMannis J, Korbling M, Champlin RE,. Fixed-dose single agent pagfolgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. Br J Haematol 2006; 133: 533-7.
12. te Poele EM, Kamps WA, Tamminga RY, Leeuw JA, Postma A, de Bont ES,. Pegfilgrastim in pediatric cancer patients. J Pediatr Hematol Oncol 2005; 27: 627-9. (Pubitemid 41697355)
13. Wendelin G, Lackner H, Schwinger W, Sovinz P, Urban C,. Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma. J Pediatr Hematol Oncol 2005; 27: 449-51. (Pubitemid 41233304)
14. Andrè N, Kababri ME, Bertrand P, Rome A, Coze C, Gentet JC, Bernard JL,. Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy. Anticancer Drugs 2007; 18: 277-81. (Pubitemid 46192980)
15. Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM,. Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res 2009; 15: 7361-7.
16. Borinstein SC, Pollard J, Winter L, Hawkins DS,. Pegfilgrastim for prevention of chemotherapy-associated neutropenia in pediatric patients with solid tumors. Pediatr Blood Cancer 2009; 53: 375-8.
17. Milano-Bausset E, Gaudart J, Rome A, Coze C, Gentet JC, Padovani L, Lacarelle B, André N,. Retrospective comparison of neutropenia in children with Ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated (G-CSF). Clin Ther 2009; 31: 2388-95.
18. Spunt SL, Irving H, Frost J, Sender L, Guo M, Yang BB, Dreiling L, Santana VM,. Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patients. J Clin Oncol 2010; 28: 1329-36.
19. Dallorso S, Berger M, Caviglia I, Emanueli T, Faraci M, Scarso L, Fagioli F, Haupt R,. Prospective single-arm study of pegfilgrastim activity and safety in children with poor-risk malignant tumours receiving chemotherapy. Bone Marrow Transplant 2008; 42: 507-13.
20. Merlin E, Zohar S, Jérme C, Veyrat-Masson R, Marceau G, Paillard C, Auvrignon A, Le Moine P, Gandemer V, Sapin V, Halle P, Boiret-Dupré N, Chevret S, Deméocq F, Dubray C, Kanold J,. Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit? Bone Marrow Transplant 2009; 43: 919-25.
21. Fritsch P, Schwinger W, Schwantzer G, Lackner H, Sovinz P, Wendelin G, Benesch M, Sipurzynski S, Urban C,. Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies. Pediatr Blood Cancer 2010; 54: 134-7.
22. Morrison VA,. An overview of the management of infection and febrile neutropenia in patients with cancer. Support Cancer Ther 2005; 2: 88-94.
23. Joint Accreditation Committee. ISCT-EBMT, FACT-JACIE, 4th ed Standards.pdf. [cited 2010 Nov 23] Available from: URL
24. Steidl U, Fenk R, Bruns I, Neumann F, Kondakci M, Hoyer B, Graf T, Rohr UP, Bork S, Kronenwett R, Haas R, Kobbe G,. Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. Bone Marrow Transplant 2005; 35: 33-6. (Pubitemid 40090053)
25. Demirer T, Ayli M, Ozcan M, Gunel N, Haznedar R, Dagli M, Fen T, Genc Y, Dincer S, Arslan O, Gürman G, Demirer S, Ozet G, Uysal A, Konuk N, Ilhan O, Koc H, Akan H,. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rh-G-CSF. Br J Haematol 2002; 116: 468-74. (Pubitemid 34155524)
26. Andre M, Badoux E, Bron D, Canon JL, DHondt V, Fassotte MF, DHondt L, Fillet G, Humblet Y, Jerusalem G, Vermeulen P, Symann M, Beguin Y,. Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignacies. Transfusion 2003; 43: 50-7. (Pubitemid 36322896)
27. Russell N, Mesters R, Schubert J, Boogaerts M, Johnsen HE, Canizo CD, Baker N, Barker P, Skacel T, Schmitz N,. A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkins lymphoma receiving chemotherapy. Haematologica 2008; 93: 405-12. (Pubitemid 351398642)